|
|
| | FARAMPATOR Basic information |
| Product Name: | FARAMPATOR | | Synonyms: | CX 691;Org 24448;FARAMPATOR;CX-691; ORG2444;Org2444;CX 691; ORG 24448; CX-691; CX691;Methanone, 2,1,3-benzoxadiazol-5-yl-1-piperidinyl-;Org24448, CX-691 | | CAS: | 211735-76-1 | | MF: | C12H13N3O2 | | MW: | 231.25 | | EINECS: | | | Product Categories: | | | Mol File: | 211735-76-1.mol |  |
| | FARAMPATOR Chemical Properties |
| Boiling point | 398.3±34.0 °C(Predicted) | | density | 1.299±0.06 g/cm3(Predicted) | | storage temp. | Sealed in dry,Store in freezer, under -20°C | | solubility | DMF: 30 mg/ml; DMF:PBS (pH7.2) (1:40): 25μg/ml; DMSO: 20 mg/ml | | form | A crystalline solid | | pka | -1.33±0.36(Predicted) | | color | White to off-white |
| | FARAMPATOR Usage And Synthesis |
| Uses | Farampator has shown effects as an AMPA receptor potentiator and glycine reuptake inhibitor with potential anti-psychotic efficacy and enhancement of prefrontal glutamatergic transmission. Farampator’s effects on both AMPA-PAMs and GlyT-1 inhibitor maybe also improve cognitive impairments in schizophrenia and in particular when combied with Risperidone (R525000). |
| | FARAMPATOR Preparation Products And Raw materials |
|